ARCADIUM LITHM (ALTM)
(Delayed Data from NYSE)
$3.53 USD
+0.15 (4.44%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $3.53 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Arcadium (ALTM) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$8.72 | $25.00 | $3.75 | 166.67% |
Price Target
Based on short-term price targets offered by 15 analysts, the average price target for Arcadium comes to $8.72. The forecasts range from a low of $3.75 to a high of $25.00. The average price target represents an increase of 166.67% from the last closing price of $3.27.
Analyst Price Targets (15)
Broker Rating
Arcadium currently has an average brokerage recommendation (ABR) of 2.06 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 16 brokerage firms. The current ABR compares to an ABR of 2.07 a month ago based on 15 recommendations.
Of the 16 recommendations deriving the current ABR, eight are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 50% and 6.25% of all recommendations. A month ago, Strong Buy represented 53.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 9 | 8 |
Buy | 1 | 1 | 0 | 0 | 0 |
Hold | 6 | 6 | 6 | 6 | 6 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.06 | 2.06 | 2.07 | 2.00 | 2.07 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/9/2024 | Raymond James | Pavel S Molchanov | Strong Buy | Strong Buy |
6/25/2024 | Not Identified | Not Identified | Not Available | Moderate Buy |
6/25/2024 | Piper Sandler | Charles N Neivert | Strong Sell | Strong Sell |
5/15/2024 | BMO Capital Markets | Joel Jackson | Hold | Hold |
5/3/2024 | Argus Research Corp. | William V Selesky | Not Available | Strong Buy |
4/9/2024 | KeyBanc Capital Markets | Aleksey Yefremov | Strong Buy | Strong Buy |
4/1/2024 | Cowen & Co. | David Deckelbaum | Strong Buy | Strong Buy |
3/1/2024 | Not Identified | Not Identified | Not Available | Hold |
2/26/2024 | Scotiabank | Ben Isaacson | Hold | Hold |
1/22/2024 | Macquarie Capital Securities | Austin Yun | Not Available | Strong Buy |
1/11/2024 | Vertical Research Partners | Kevin W Mccarthy | Not Available | Hold |
12/28/2023 | Mizuho SecuritiesUSA | John Roberts | Hold | Hold |
11/6/2023 | Loop Capital Markets | Christopher Kapsch | Not Available | Strong Buy |
10/23/2023 | B. Riley Securities | Matthew A Key | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.06 |
ABR (Last week) | 2.06 |
# of Recs in ABR | 16 |
Average Target Price | $8.72 |
LT Growth Rate | 21.10% |
Industry | Chemical - Specialty |
Industry Rank by ABR | 63 of 252 |
Current Quarter EPS Est: | 0.05 |